J&J hires Bayer exec to oversee quality; Pfizer adding 600 to operations in China;

> Johnson & Johnson ($JNJ) hired former Bayer executive Sandra Peterson to oversee its troubled consumer health unit and manufacturing operations. Story

> Johnson & Johnson's Ethicon will invest $185 million to build a new plant in Athens, GA, to make sutures. Story

> Medical device maker Covidien ($COV) told its 595 employees at a plant in Seneca, SC, that the facility will be closed within three years and production moved to a plant in Costa Rica. Story

> Xcelience says it is opening a 24,000-square-foot facility in Tampa, FL, for  secondary packaging, labeling, distribution and warehouse services. Item

> The FDA cited French in vitro diagnostics player bioMérieux for a number of quality violations in a North Carolina manufacturing facility. Story

And Finally... The joint venture of Pfizer ($PFE) and Zhejiang Hisun Pharmaceutical will hire 600 people in China by the end of the year for manufacturing as well as R&D and support functions. Story

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)